What is Decoy Therapeutics Inc. Common Stock's Market Cap?

Decoy Therapeutics Inc. Common Stock's Market Cap is $1.8M, based on as-reported figures from SEC (XBRL) filings.

What is Decoy Therapeutics Inc. Common Stock's Enterprise Value?

Decoy Therapeutics Inc. Common Stock's Enterprise Value is -$6.5M, based on as-reported figures from SEC (XBRL) filings.

What is Decoy Therapeutics Inc. Common Stock's EV / EBITDA?

Decoy Therapeutics Inc. Common Stock's EV / EBITDA is 0.4×, based on as-reported figures from SEC (XBRL) filings.

What is Decoy Therapeutics Inc. Common Stock's Net Income (TTM)?

Decoy Therapeutics Inc. Common Stock's Net Income (TTM) is -$14.4M, based on as-reported figures from SEC (XBRL) filings.

What is Decoy Therapeutics Inc. Common Stock's EBITDA?

Decoy Therapeutics Inc. Common Stock's EBITDA is -$14.8M, based on as-reported figures from SEC (XBRL) filings.

What is Decoy Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Decoy Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -22.05, based on as-reported figures from SEC (XBRL) filings.

What is Decoy Therapeutics Inc. Common Stock's Net Debt?

Decoy Therapeutics Inc. Common Stock's Net Debt is -$8.3M, based on as-reported figures from SEC (XBRL) filings.

Decoy Therapeutics Inc. Common Stock (DCOY) Financial Statements

Decoy Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00740LLF3

XNAS · usd

2.77▲ 0.14 (5.32%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.63

Day's Range2.63 – 2.85

52-Week Range0.53 – 13.51

Volume29.2K

Avg Volume28.0K

Share Statistics

Shares Outstanding

Employees11

ExchangeXNAS

Listed2015-01-29

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Decoy Therapeutics Inc. Common Stock (DCOY)

What is Decoy Therapeutics Inc. Common Stock's Market Cap?: Decoy Therapeutics Inc. Common Stock's Market Cap is $1.8M, based on as-reported figures from SEC (XBRL) filings.
What is Decoy Therapeutics Inc. Common Stock's Enterprise Value?: Decoy Therapeutics Inc. Common Stock's Enterprise Value is -$6.5M, based on as-reported figures from SEC (XBRL) filings.
What is Decoy Therapeutics Inc. Common Stock's EV / EBITDA?: Decoy Therapeutics Inc. Common Stock's EV / EBITDA is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Decoy Therapeutics Inc. Common Stock's Net Income (TTM)?: Decoy Therapeutics Inc. Common Stock's Net Income (TTM) is -$14.4M, based on as-reported figures from SEC (XBRL) filings.
What is Decoy Therapeutics Inc. Common Stock's EBITDA?: Decoy Therapeutics Inc. Common Stock's EBITDA is -$14.8M, based on as-reported figures from SEC (XBRL) filings.
What is Decoy Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Decoy Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -22.05, based on as-reported figures from SEC (XBRL) filings.
What is Decoy Therapeutics Inc. Common Stock's Net Debt?: Decoy Therapeutics Inc. Common Stock's Net Debt is -$8.3M, based on as-reported figures from SEC (XBRL) filings.